nodes	percent_of_prediction	percent_of_DWPC	metapath
Dorzolamide—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0525	0.302	CbGbCtD
Dorzolamide—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0329	0.189	CbGbCtD
Dorzolamide—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0306	0.175	CbGbCtD
Dorzolamide—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0225	0.129	CbGbCtD
Dorzolamide—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.014	0.0806	CbGbCtD
Dorzolamide—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0129	0.0738	CbGbCtD
Dorzolamide—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00877	0.0504	CbGbCtD
Dorzolamide—Cardiac failure—Doxorubicin—peripheral nervous system neoplasm	0.000663	0.000803	CcSEcCtD
Dorzolamide—Mood swings—Epirubicin—peripheral nervous system neoplasm	0.000663	0.000803	CcSEcCtD
Dorzolamide—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000661	0.0008	CcSEcCtD
Dorzolamide—Cerebrovascular accident—Doxorubicin—peripheral nervous system neoplasm	0.000661	0.0008	CcSEcCtD
Dorzolamide—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000659	0.000798	CcSEcCtD
Dorzolamide—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000659	0.000798	CcSEcCtD
Dorzolamide—Rash—Topotecan—peripheral nervous system neoplasm	0.000659	0.000798	CcSEcCtD
Dorzolamide—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000658	0.000797	CcSEcCtD
Dorzolamide—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000658	0.000797	CcSEcCtD
Dorzolamide—Cough—Etoposide—peripheral nervous system neoplasm	0.000656	0.000794	CcSEcCtD
Dorzolamide—Headache—Topotecan—peripheral nervous system neoplasm	0.000655	0.000793	CcSEcCtD
Dorzolamide—Rash—Tretinoin—peripheral nervous system neoplasm	0.000654	0.000792	CcSEcCtD
Dorzolamide—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000654	0.000792	CcSEcCtD
Dorzolamide—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000653	0.000791	CcSEcCtD
Dorzolamide—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000653	0.000791	CcSEcCtD
Dorzolamide—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000653	0.000791	CcSEcCtD
Dorzolamide—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000651	0.000788	CcSEcCtD
Dorzolamide—Headache—Tretinoin—peripheral nervous system neoplasm	0.00065	0.000787	CcSEcCtD
Dorzolamide—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00065	0.000787	CcSEcCtD
Dorzolamide—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000649	0.000786	CcSEcCtD
Dorzolamide—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000648	0.000784	CcSEcCtD
Dorzolamide—Pain—Vincristine—peripheral nervous system neoplasm	0.000648	0.000784	CcSEcCtD
Dorzolamide—Diplopia—Doxorubicin—peripheral nervous system neoplasm	0.000647	0.000784	CcSEcCtD
Dorzolamide—Pain in extremity—Doxorubicin—peripheral nervous system neoplasm	0.000647	0.000784	CcSEcCtD
Dorzolamide—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000647	0.000784	CcSEcCtD
Dorzolamide—Rash—Melphalan—peripheral nervous system neoplasm	0.000645	0.000781	CcSEcCtD
Dorzolamide—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000645	0.000781	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000643	0.000778	CcSEcCtD
Dorzolamide—Chest pain—Etoposide—peripheral nervous system neoplasm	0.00064	0.000775	CcSEcCtD
Dorzolamide—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000638	0.000773	CcSEcCtD
Dorzolamide—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.000637	0.000772	CcSEcCtD
Dorzolamide—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000632	0.000766	CcSEcCtD
Dorzolamide—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.00063	0.000763	CcSEcCtD
Dorzolamide—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000626	0.000758	CcSEcCtD
Dorzolamide—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000624	0.000756	CcSEcCtD
Dorzolamide—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000624	0.000756	CcSEcCtD
Dorzolamide—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000621	0.000752	CcSEcCtD
Dorzolamide—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000621	0.000752	CcSEcCtD
Dorzolamide—Nausea—Topotecan—peripheral nervous system neoplasm	0.000621	0.000752	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000619	0.00075	CcSEcCtD
Dorzolamide—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000619	0.000749	CcSEcCtD
Dorzolamide—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000616	0.000746	CcSEcCtD
Dorzolamide—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000616	0.000746	CcSEcCtD
Dorzolamide—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000616	0.000745	CcSEcCtD
Dorzolamide—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000613	0.000743	CcSEcCtD
Dorzolamide—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000613	0.000743	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.00061	0.000739	CcSEcCtD
Dorzolamide—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000608	0.000736	CcSEcCtD
Dorzolamide—Nausea—Melphalan—peripheral nervous system neoplasm	0.000608	0.000736	CcSEcCtD
Dorzolamide—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000605	0.000732	CcSEcCtD
Dorzolamide—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000601	0.000728	CcSEcCtD
Dorzolamide—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000599	0.000725	CcSEcCtD
Dorzolamide—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000599	0.000725	CcSEcCtD
Dorzolamide—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000597	0.000723	CcSEcCtD
Dorzolamide—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000593	0.000718	CcSEcCtD
Dorzolamide—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000589	0.000713	CcSEcCtD
Dorzolamide—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000585	0.000708	CcSEcCtD
Dorzolamide—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.000583	0.000706	CcSEcCtD
Dorzolamide—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000582	0.000705	CcSEcCtD
Dorzolamide—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000582	0.000704	CcSEcCtD
Dorzolamide—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00058	0.000702	CcSEcCtD
Dorzolamide—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000579	0.000701	CcSEcCtD
Dorzolamide—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000573	0.000694	CcSEcCtD
Dorzolamide—Pain—Cisplatin—peripheral nervous system neoplasm	0.000573	0.000693	CcSEcCtD
Dorzolamide—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000565	0.000685	CcSEcCtD
Dorzolamide—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000564	0.000683	CcSEcCtD
Dorzolamide—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000562	0.00068	CcSEcCtD
Dorzolamide—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000559	0.000677	CcSEcCtD
Dorzolamide—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000558	0.000676	CcSEcCtD
Dorzolamide—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000556	0.000673	CcSEcCtD
Dorzolamide—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000552	0.000668	CcSEcCtD
Dorzolamide—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000551	0.000667	CcSEcCtD
Dorzolamide—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000547	0.000662	CcSEcCtD
Dorzolamide—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000547	0.000662	CcSEcCtD
Dorzolamide—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000545	0.00066	CcSEcCtD
Dorzolamide—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000545	0.00066	CcSEcCtD
Dorzolamide—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000545	0.00066	CcSEcCtD
Dorzolamide—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000543	0.000658	CcSEcCtD
Dorzolamide—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000539	0.000653	CcSEcCtD
Dorzolamide—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000538	0.000652	CcSEcCtD
Dorzolamide—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000538	0.000651	CcSEcCtD
Dorzolamide—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000535	0.000647	CcSEcCtD
Dorzolamide—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000534	0.000647	CcSEcCtD
Dorzolamide—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000533	0.000646	CcSEcCtD
Dorzolamide—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000529	0.000641	CcSEcCtD
Dorzolamide—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000529	0.00064	CcSEcCtD
Dorzolamide—Pain—Etoposide—peripheral nervous system neoplasm	0.000525	0.000635	CcSEcCtD
Dorzolamide—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000524	0.000635	CcSEcCtD
Dorzolamide—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000524	0.000635	CcSEcCtD
Dorzolamide—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000523	0.000633	CcSEcCtD
Dorzolamide—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.00052	0.00063	CcSEcCtD
Dorzolamide—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00052	0.000629	CcSEcCtD
Dorzolamide—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000518	0.000627	CcSEcCtD
Dorzolamide—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000517	0.000626	CcSEcCtD
Dorzolamide—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000509	0.000616	CcSEcCtD
Dorzolamide—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000506	0.000613	CcSEcCtD
Dorzolamide—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000506	0.000612	CcSEcCtD
Dorzolamide—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000506	0.000612	CcSEcCtD
Dorzolamide—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000505	0.000611	CcSEcCtD
Dorzolamide—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000503	0.00061	CcSEcCtD
Dorzolamide—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000503	0.000609	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000502	0.000607	CcSEcCtD
Dorzolamide—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000501	0.000606	CcSEcCtD
Dorzolamide—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.0005	0.000605	CcSEcCtD
Dorzolamide—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000496	0.0006	CcSEcCtD
Dorzolamide—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000495	0.000599	CcSEcCtD
Dorzolamide—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000495	0.000599	CcSEcCtD
Dorzolamide—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000493	0.000597	CcSEcCtD
Dorzolamide—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000493	0.000597	CcSEcCtD
Dorzolamide—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000492	0.000596	CcSEcCtD
Dorzolamide—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000487	0.00059	CcSEcCtD
Dorzolamide—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000485	0.000587	CcSEcCtD
Dorzolamide—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000485	0.000587	CcSEcCtD
Dorzolamide—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000485	0.000587	CcSEcCtD
Dorzolamide—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000485	0.000587	CcSEcCtD
Dorzolamide—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000481	0.000583	CcSEcCtD
Dorzolamide—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00048	0.000582	CcSEcCtD
Dorzolamide—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.00048	0.000582	CcSEcCtD
Dorzolamide—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000478	0.000579	CcSEcCtD
Dorzolamide—Rash—Vincristine—peripheral nervous system neoplasm	0.000477	0.000578	CcSEcCtD
Dorzolamide—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000477	0.000578	CcSEcCtD
Dorzolamide—Headache—Vincristine—peripheral nervous system neoplasm	0.000474	0.000574	CcSEcCtD
Dorzolamide—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000471	0.00057	CcSEcCtD
Dorzolamide—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000468	0.000567	CcSEcCtD
Dorzolamide—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000467	0.000565	CcSEcCtD
Dorzolamide—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000466	0.000565	CcSEcCtD
Dorzolamide—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000466	0.000564	CcSEcCtD
Dorzolamide—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000458	0.000555	CcSEcCtD
Dorzolamide—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000458	0.000554	CcSEcCtD
Dorzolamide—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000456	0.000552	CcSEcCtD
Dorzolamide—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000452	0.000547	CcSEcCtD
Dorzolamide—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000451	0.000546	CcSEcCtD
Dorzolamide—Nausea—Vincristine—peripheral nervous system neoplasm	0.00045	0.000545	CcSEcCtD
Dorzolamide—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000444	0.000538	CcSEcCtD
Dorzolamide—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00044	0.000533	CcSEcCtD
Dorzolamide—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000434	0.000526	CcSEcCtD
Dorzolamide—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000432	0.000524	CcSEcCtD
Dorzolamide—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000432	0.000523	CcSEcCtD
Dorzolamide—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000428	0.000518	CcSEcCtD
Dorzolamide—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000426	0.000516	CcSEcCtD
Dorzolamide—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000423	0.000513	CcSEcCtD
Dorzolamide—Rash—Cisplatin—peripheral nervous system neoplasm	0.000422	0.000511	CcSEcCtD
Dorzolamide—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000422	0.000511	CcSEcCtD
Dorzolamide—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000421	0.00051	CcSEcCtD
Dorzolamide—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00042	0.000508	CcSEcCtD
Dorzolamide—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000418	0.000506	CcSEcCtD
Dorzolamide—Tension—Epirubicin—peripheral nervous system neoplasm	0.000413	0.000501	CcSEcCtD
Dorzolamide—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000413	0.0005	CcSEcCtD
Dorzolamide—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000409	0.000495	CcSEcCtD
Dorzolamide—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000408	0.000493	CcSEcCtD
Dorzolamide—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000406	0.000491	CcSEcCtD
Dorzolamide—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.0004	0.000484	CcSEcCtD
Dorzolamide—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000398	0.000482	CcSEcCtD
Dorzolamide—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000397	0.000481	CcSEcCtD
Dorzolamide—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000396	0.000479	CcSEcCtD
Dorzolamide—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00039	0.000472	CcSEcCtD
Dorzolamide—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.00039	0.000472	CcSEcCtD
Dorzolamide—Rash—Etoposide—peripheral nervous system neoplasm	0.000387	0.000468	CcSEcCtD
Dorzolamide—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000386	0.000468	CcSEcCtD
Dorzolamide—Headache—Etoposide—peripheral nervous system neoplasm	0.000384	0.000465	CcSEcCtD
Dorzolamide—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000383	0.000463	CcSEcCtD
Dorzolamide—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000382	0.000462	CcSEcCtD
Dorzolamide—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000379	0.000458	CcSEcCtD
Dorzolamide—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000379	0.000458	CcSEcCtD
Dorzolamide—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000378	0.000458	CcSEcCtD
Dorzolamide—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000377	0.000457	CcSEcCtD
Dorzolamide—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000372	0.000451	CcSEcCtD
Dorzolamide—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.00037	0.000448	CcSEcCtD
Dorzolamide—Cough—Epirubicin—peripheral nervous system neoplasm	0.000368	0.000445	CcSEcCtD
Dorzolamide—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000367	0.000445	CcSEcCtD
Dorzolamide—Nausea—Etoposide—peripheral nervous system neoplasm	0.000364	0.000441	CcSEcCtD
Dorzolamide—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000364	0.00044	CcSEcCtD
Dorzolamide—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000359	0.000434	CcSEcCtD
Dorzolamide—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000359	0.000434	CcSEcCtD
Dorzolamide—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000357	0.000433	CcSEcCtD
Dorzolamide—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000354	0.000429	CcSEcCtD
Dorzolamide—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000351	0.000425	CcSEcCtD
Dorzolamide—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.00035	0.000424	CcSEcCtD
Dorzolamide—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.00035	0.000423	CcSEcCtD
Dorzolamide—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000347	0.00042	CcSEcCtD
Dorzolamide—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000345	0.000417	CcSEcCtD
Dorzolamide—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000344	0.000416	CcSEcCtD
Dorzolamide—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000344	0.000416	CcSEcCtD
Dorzolamide—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000343	0.000415	CcSEcCtD
Dorzolamide—Cough—Doxorubicin—peripheral nervous system neoplasm	0.00034	0.000412	CcSEcCtD
Dorzolamide—Shock—Epirubicin—peripheral nervous system neoplasm	0.000338	0.00041	CcSEcCtD
Dorzolamide—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000337	0.000408	CcSEcCtD
Dorzolamide—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000332	0.000403	CcSEcCtD
Dorzolamide—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000332	0.000402	CcSEcCtD
Dorzolamide—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000332	0.000402	CcSEcCtD
Dorzolamide—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000331	0.0004	CcSEcCtD
Dorzolamide—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000328	0.000397	CcSEcCtD
Dorzolamide—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000328	0.000397	CcSEcCtD
Dorzolamide—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000325	0.000393	CcSEcCtD
Dorzolamide—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000321	0.000389	CcSEcCtD
Dorzolamide—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000321	0.000388	CcSEcCtD
Dorzolamide—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000318	0.000385	CcSEcCtD
Dorzolamide—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000318	0.000385	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000313	0.000379	CcSEcCtD
Dorzolamide—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000313	0.000379	CcSEcCtD
Dorzolamide—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000311	0.000377	CcSEcCtD
Dorzolamide—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000309	0.000374	CcSEcCtD
Dorzolamide—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000308	0.000372	CcSEcCtD
Dorzolamide—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000307	0.000371	CcSEcCtD
Dorzolamide—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000306	0.00037	CcSEcCtD
Dorzolamide—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000303	0.000367	CcSEcCtD
Dorzolamide—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000303	0.000367	CcSEcCtD
Dorzolamide—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000299	0.000362	CcSEcCtD
Dorzolamide—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000297	0.00036	CcSEcCtD
Dorzolamide—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000296	0.000359	CcSEcCtD
Dorzolamide—Pain—Epirubicin—peripheral nervous system neoplasm	0.000294	0.000356	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.00029	0.000351	CcSEcCtD
Dorzolamide—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000288	0.000348	CcSEcCtD
Dorzolamide—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000286	0.000346	CcSEcCtD
Dorzolamide—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000284	0.000343	CcSEcCtD
Dorzolamide—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000283	0.000343	CcSEcCtD
Dorzolamide—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000283	0.000342	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000281	0.00034	CcSEcCtD
Dorzolamide—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.00028	0.000339	CcSEcCtD
Dorzolamide—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000277	0.000335	CcSEcCtD
Dorzolamide—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000274	0.000332	CcSEcCtD
Dorzolamide—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000273	0.000331	CcSEcCtD
Dorzolamide—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000272	0.000329	CcSEcCtD
Dorzolamide—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000272	0.000329	CcSEcCtD
Dorzolamide—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000272	0.000329	CcSEcCtD
Dorzolamide—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000262	0.000317	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.00026	0.000315	CcSEcCtD
Dorzolamide—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000253	0.000307	CcSEcCtD
Dorzolamide—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000253	0.000306	CcSEcCtD
Dorzolamide—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000252	0.000305	CcSEcCtD
Dorzolamide—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000252	0.000305	CcSEcCtD
Dorzolamide—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000247	0.000299	CcSEcCtD
Dorzolamide—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000243	0.000295	CcSEcCtD
Dorzolamide—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000235	0.000285	CcSEcCtD
Dorzolamide—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.000284	CcSEcCtD
Dorzolamide—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000228	0.000276	CcSEcCtD
Dorzolamide—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000227	0.000275	CcSEcCtD
Dorzolamide—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.000273	CcSEcCtD
Dorzolamide—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000219	0.000265	CcSEcCtD
Dorzolamide—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000218	0.000264	CcSEcCtD
Dorzolamide—Rash—Epirubicin—peripheral nervous system neoplasm	0.000217	0.000263	CcSEcCtD
Dorzolamide—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000217	0.000262	CcSEcCtD
Dorzolamide—Headache—Epirubicin—peripheral nervous system neoplasm	0.000215	0.000261	CcSEcCtD
Dorzolamide—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.000255	CcSEcCtD
Dorzolamide—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000204	0.000247	CcSEcCtD
Dorzolamide—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000202	0.000245	CcSEcCtD
Dorzolamide—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000201	0.000243	CcSEcCtD
Dorzolamide—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.000243	CcSEcCtD
Dorzolamide—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.000241	CcSEcCtD
Dorzolamide—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.000229	CcSEcCtD
